+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Acute Ischemic Stroke Therapeutics Market 2024-2028 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 184 Pages
  • Global
From
Respiratory Disease Vaccine Market Report 2025 - Product Thumbnail Image

Respiratory Disease Vaccine Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 167 Pages
  • Global
From
Thyroid Cancer Drugs Market Report 2025 - Product Thumbnail Image

Thyroid Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Loading Indicator